Spearman’s rho | p | |
---|---|---|
mNAPSI vs | ||
Duration of arthritis (years) | 0.12 | 0.46 |
Duration of psoriasis (years) | 0.09 | 0.54 |
SJC (swollen joint count) | −0.18 | 0.27 |
TJC (tender joint count) | −0.07 | 0.67 |
PASI | 0.32 | 0.04 |
Physician nail assessment | 0.99 | < 0.0001 |
Physician VAS global | 0.04 | 0.78 |
Physician VAS skin | 0.29 | 0.07 |
Physician VAS joint | –0.25 | 0.12 |
Patient VAS global | 0.08 | 0.61 |
Patient VAS skin | 0.19 | 0.23 |
Patient VAS joint | −0.05 | 0.75 |
HAQ | −0.04 | 0.81 |
Physician nail assessment vs | ||
Duration of arthritis | 0.11 | 0.49 |
Duration of psoriasis | 0.09 | 0.59 |
SJC | −0.18 | 0.26 |
TJC | −0.07 | 0.66 |
PASI | 0.31 | 0.05 |
mNAPSI | 0.99 | < 0.0001 |
Physician VAS global | 0.03 | 0.83 |
Physician VAS skin | 0.28 | 0.08 |
Physician VAS joint | −0.25 | 0.11 |
Patient VAS global | 0.08 | 0.63 |
Patient VAS skin | 0.19 | 0.24 |
Patient VAS joint | −0.05 | 0.74 |
HAQ | −0.04 | 0.80 |
mNAPSI: modified Nail Psoriasis Severity Index; VAS: visual analog scale; PASI: Psoriasis Area and Severity Index; HAQ: Health Assessment Questionnaire.